Thymus histology and concomitant autoimmune diseases in Japanese patients with muscle-specific receptor tyrosine kinase-antibody-positive myasthenia gravis

被引:19
|
作者
Nakata, R. [1 ]
Motomura, M. [1 ]
Masuda, T. [1 ]
Shiraishi, H. [1 ]
Tokuda, M. [1 ]
Fukuda, T. [1 ]
Ando, T. [1 ]
Yoshimura, T. [1 ]
Tsujihata, M. [2 ,3 ]
Kawakami, A. [1 ]
机构
[1] Nagasaki Univ, Dept Clin Neurosci & Neurol, Grad Sch Biomed Sci, Nagasaki 8528501, Japan
[2] Nagasaki Univ, Sch Hlth Sci, Nagasaki 8528501, Japan
[3] Nagasaki Kita Hosp, Nagasaki, Japan
关键词
associated autoimmune disease; muscle-specific receptor tyrosine kinase; myasthenia gravis; thymus; titin antibodies; TITIN ANTIBODIES; ACETYLCHOLINE-RECEPTORS; MYOID CELLS; MUSK; AUTOANTIBODIES; THYMOMA; HETEROGENEITY; FEATURES; MG;
D O I
10.1111/ene.12169
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background and purpose: The differences in the characteristics of thymus histology, coexisting autoimmune diseases and related autoantibodies between anti-muscle-specific receptor tyrosine kinase (MuSK)-antibody (Ab)-positive myasthenia gravis (MG) patients, and anti-acetylcholine receptor (AChR)-Ab-positive MG patients are not clearly defined. Methods: The types of thymus histology, coexisting autoimmune diseases and associated Abs in 83 MuSK-Ab-positive patients nationwide were investigated and were compared with those in AChR-Ab-positive patients followed at our institute (n = 83). As for the autoantibodies associated with thymoma, titin Abs were measured. Results: Thymoma was not present in any of the MuSK-Ab-positive patients but presented in 21 patients (25.3%) amongst the AChR-Ab-positive patients. Titin Abs were absent in MuSK-Ab-positive patients but positive in 25 (30.1%) of the AChR-Ab-positive patients. Concomitant autoimmune diseases were present in eight MuSK-Ab-positive patients (9.6%) amongst whom Hashimoto's thyroiditis and rheumatoid arthritis predominated, whereas 22 AChR-Ab-positive patients (26.5%) had one or more concomitant autoimmune diseases of which Graves' disease predominated. Conclusions: Differences in frequency of thymoma and thymic hyperplasia, coexisting autoimmune diseases and autoantibody positivity between MuSK-Ab-positive and AChR-Ab-positive MG were indicated, suggesting that, in contrast with AChR-Ab-positive MG, thymus does not seem to be involved in the pathogenic mechanisms of MuSK-Ab-positive MG.
引用
收藏
页码:1272 / 1276
页数:5
相关论文
共 50 条
  • [1] Muscle-Specific Receptor Tyrosine Kinase Antibody Positive Myasthenia Gravis Current Status
    Oh, Shin Joong
    JOURNAL OF CLINICAL NEUROLOGY, 2009, 5 (02): : 53 - 64
  • [2] Update on muscle-specific tyrosine kinase antibody positive myasthenia gravis
    Guptill, Jeffrey T.
    Sanders, Donald B.
    CURRENT OPINION IN NEUROLOGY, 2010, 23 (05) : 530 - 535
  • [3] Muscle-Specific Receptor Tyrosine Kinase (MuSK) Myasthenia Gravis
    Hurst, Rebecca L.
    Gooch, Clifton L.
    CURRENT NEUROLOGY AND NEUROSCIENCE REPORTS, 2016, 16 (07)
  • [4] Muscle-Specific Receptor Tyrosine Kinase (MuSK) Myasthenia Gravis
    Rebecca L. Hurst
    Clifton L. Gooch
    Current Neurology and Neuroscience Reports, 2016, 16
  • [5] Muscle-Specific Tyrosine Kinase and Myasthenia Gravis Owing to Other Antibodies
    Rivner, Michael H.
    Pasnoor, Mamatha
    Dimachkie, Mazen M.
    Barohn, Richard J.
    Mei, Lin
    NEUROLOGIC CLINICS, 2018, 36 (02) : 293 - +
  • [6] Clinical phenotype of muscle-specific tyrosine kinase-antibody positive myasthenia gravis
    Wolfe, Gil I.
    Oh, Shin J.
    MYASTHENIA GRAVIS AND RELATED DISORDERS: 11TH INTERNATIONAL CONFERENCE, 2008, 1132 : 71 - 75
  • [7] Clinical features and outcomes of patients with muscle-specific kinase antibody-positive myasthenia gravis in Japan
    Yasuda, Manato
    Uzawa, Akiyuki
    Kuwabara, Satoshi
    Suzuki, Shigeaki
    Akamine, Hiroyuki
    Onishi, Yosuke
    Ozawa, Yukiko
    Kawaguchi, Naoki
    Kubota, Tomoya
    Takahashi, Masanori P.
    Suzuki, Yasushi
    Watanabe, Genya
    Kimura, Takashi
    Sugimoto, Takamichi
    Samukawa, Makoto
    Minami, Naoya
    Masuda, Masayuki
    Konno, Shingo
    Nagane, Yuriko
    Utsugisawa, Kimiaki
    JOURNAL OF NEUROIMMUNOLOGY, 2023, 385
  • [8] Antibodies against Wnt receptor of muscle-specific tyrosine kinase in myasthenia gravis
    Takamori, Masaharu
    Nakamura, Tatsufumi
    Motomura, Masakatsu
    JOURNAL OF NEUROIMMUNOLOGY, 2013, 254 (1-2) : 183 - 186
  • [9] Proteolytic ectodomain shedding of muscle-specific tyrosine kinase in myasthenia gravis
    Mori, Shuuichi
    Suzuki, Shigeaki
    Konishi, Tetsuro
    Kawaguchi, Naoki
    Kishi, Masahiko
    Kuwabara, Satoshi
    Ishizuchi, Kei
    Zhou, Heying
    Shibasaki, Futoshi
    Tsumoto, Hiroki
    Omura, Takuya
    Miura, Yuri
    Mori, Seijiro
    Higashihara, Mana
    Murayama, Shigeo
    Shigemoto, Kazuhiro
    EXPERIMENTAL NEUROLOGY, 2023, 361
  • [10] Management challenges in muscle-specific tyrosine kinase myasthenia gravis
    Evoli, Amelia
    Alboini, Paolo E.
    Bisonni, Ana
    Mastrorosa, Alessia
    Bartocccioni, Emanuela
    MYASTHENIA GRAVIS AND RELATED DISORDERS I, 2012, 1274 : 86 - 91